Phibro Animal Health (PAHC) Misses Q1 EPS by 6c; Offers FY23 Guidance

Phibro Animal Health (NASDAQ: PAHC) reported Q1 EPS of $0.21, $0.06 worse than the analyst estimate of $0.27. Revenue for the quarter came in at $232.5 million versus the consensus estimate of $221.5 million.

GUIDANCE:

Phibro Animal Health sees FY2023 EPS of $1.21-$1.31, versus the consensus of $1.27. Phibro Animal Health sees FY2023 revenue of $0.96-1 billion, versus the consensus of $0.98 billion.

For earnings history and earnings-related data on Phibro Animal Health (PAHC) click here.

You May Also Be Interested In

• LeonaBio (LONA) Price Target Cut to $17 by Citizens Amid Pipeline Development
• LeonaBio, Inc. (LONA) Tops Q2 EPS by 32c
• Investcorp Credit Management BDC, Inc. (ICMB) Misses Q2 EPS by 12c